ENGN
NASDAQ
$1.87
enGene Holdings Inc (ENGN)
enGene Holdings Inc., through its subsidiary enGene, Inc., is a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. The company is headquartered in Saint-Laurent, Canada.
This company is also listed under the following ticker: ENGNW.
Website: https://www.engene.comSector:
Healthcare
Industry:
Biotechnology
Hold
Target: $3.29 (+75.72%)
Market Cap
$127M
P/B Ratio
0.50
Free Cash Flow Yield
-87.51%
Beta (5Y)
0.91
Price Chart
Valuation
Market Cap$127M
P/B0.50
Profitability
EBITDA-$132M
EPS-$2.19
Financial Health
Free Cash Flow Yield-87.51%
Growth & Risk
Beta (5Y)0.91
Sharpe Ratio0.42